FMC has joined other US dialysis providers, such as DaVita, and patient advocates in filing a lawsuit challenging the rulemaking process used by the United States Centers for MediCare and Medicaid Services (CMS) to promulgate a new regulation regarding premium assistance programmes that help to fund insurance premiums for patients with end-stage renal disease (ESRD).
09 Jan 2017
Disliked charity?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Disliked charity?
Fresenius Medical Care AG (FME:WBO) | 0 0 0.7% | Mkt Cap: 26,769m
- Published:
09 Jan 2017 -
Author:
Martin Schnee -
Pages:
3
FMC has joined other US dialysis providers, such as DaVita, and patient advocates in filing a lawsuit challenging the rulemaking process used by the United States Centers for MediCare and Medicaid Services (CMS) to promulgate a new regulation regarding premium assistance programmes that help to fund insurance premiums for patients with end-stage renal disease (ESRD).